Surgical resection in the treatment of stages I-II of small cell lung carcinoma (SCLC)
Cataldo, I.; Bedini, A.V.; Muscolino, G.; Valente, M.; Pastorino, U.; Bidoli, P.; Pilotti, S.; Ravasi, G.
Tumori 75(1): 28-30
1989
ISSN/ISBN: 0300-8916 PMID: 2540577 Document Number: 340012
From 1981 to 1986, 17 patients with resected small cell lung carcinoma (SCLC) staged as I or II according to the new TNM classification were recruited for a prospective study to evaluate the effectiveness of surgery and postoperative chemotherapy (plus locoregional radiotherapy only when a nonradical resection was accomplished) in the treatment of early stages of the disease. Six patients received full protocol chemotherapy (6 courses) and 8 a mean of 79.1% of the planned courses. Three patients received non adjuvant treatment. Locoregional radiotherapy for residual disease was administered in 2 cases. One patient died for myelosuppression due to chemotherapy and 10 for recurrences of cancer, all within the 20th postoperative month. Metastases accounted 80% of overall recurrences. Six patients were alive and tumor-free at 18, 22, 39, 44, 47 and 51 months from resection. Actuarial observed 3-year survival was 32%.